GPT and COVID-19: In a retrospective cohort study in Romania, Crisan et al. found that among 370 consecutive patients with moderate and severe COVID-19 and no preexisting liver disease, 72.9% had liver abnormalities at admission (AST and ALT mildly increased, and median peak values of <5 ULN).